UNC13A Restoration as a Novel Genetically Validated Approach to ALS

Time: 10:30 am
day: Conference Day Two Workshop B

Details:

  • Exploring Genetics in ALS: across rare Familial Forms and sporadic population
  • Target validation, mechanisms and biology of UNC13A
  • Discovery and development of medicines for UNC13A

Speakers: